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Abstract
Background: Patients with functional aortic interruption of the descending thoracic aorta at the isthmus due to
severe coarctation in association with atretic lumen are extremely rare in the adult population. The management is
challenging and carries high morbidity and mortality.
Case presentation: We describe successful percutaneous reconstruction using a covered stent in a similar patient
who is doing well two-years after intervention. A literature search was done to explore management strategies and
their long-term outcomes for better understanding.
Conclusions: This report is an attempt to highlight the role of minimal invasive approach in the management of
rare, severe coarctation of the aorta in adult patients to avoid morbidity and mortality associated with more
invasive procedures.
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Background
Patients with functional aortic interruption of the
descending thoracic aorta at the isthmus due to severe
coarctation of aorta (CoA) and atresia are extremely rare
and seldom attain advance age [1–4]. Coarctation of the
aorta accounts for 5 to 10 % of all congenital cardiovascu-
lar malformations [1]. The available treatment modalities
include surgery, balloon angioplasty and endovascular
stenting [1–13]. However, management strategies are de-
batable due to limited and variable long-term outcomes
[10–13]. We report herewith, an adult male with severe
CoA of proximal descending aortic segment associated
with atretic lumen, which underwent successful percutan-
eous reconstruction using a covered stent and required
re-intervention later.
Case presentation
A 27-year-old male with recently diagnosed severe CoA
was referred to us with history of refractory hypertension
and shortness of breath (NYHA II) of three years dur-
ation. There was no history of trauma or surgery. Also,
there was no claudication. On physical examination, the
blood pressure in the right upper limb was 200/120 mm
Hg. A radio-femoral delay was apparent and a pressure
gradient of 90 mm Hg was noted between the upper and
lower extremities. The pulsations in the lower limbs were
faint. Routine blood chemistry and urine analysis was un-
remarkable. A chest x-ray delineated rib notching. A 2-D
echocardiogram revealed a bicuspid aortic valve with mild
stenosis and left ventricular hypertrophy with mild impair-
ment. A contrast CT angiogram showed a severe CoA of
the descending aorta at the isthmus involving a 4 cm long
segment with merely 1–2 mm lumen and a gradient of
90 mm Hg with a diastolic runoff.
A decision was made to proceed with a transcatheter
stent implantation at the Coarctation/atretic aortic seg-
ment under general anaesthesia. A 14 F sheath was placed
in the right femoral artery via a surgical cut down. An
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initial angiogram revealed a blind end at the level of the
coarctation (Fig. 1a).
The initial management plan was to approach via right
axillary artery with a “kissing technique” to perforate the
atretic segment. However, while manipulating a straight
Terumo™ wire through the distal part of the aorta,
incidentally the wire went through the membranous
atretic lumen of the aorta. The diameter of atretic aortic
lumen was 1.2 mm (Fig. 1b).The subsequent angiogram
however confirmed the absence of any resultant vascular
complication. Therefore, we proceeded further.
A 45 mm PTFE covered Cheatham-Platinum stent was
positioned successfully at the coarctation through a 14 F
Mullins sheath. A 16 mm X 4 cm Z-Med™ balloon was
used to successfully inflate the stent distal to the left
subclavian origin (Fig. 2a). Post implantation gradient
was noted to be about 3 mm Hg. The patient went on to
make an uneventful recovery and was discharged home.
At 1-year follow up, an aortogram revealed good flow in
the involved segment without any significant gradient.
At 2-year follow up, an echocardiographic evidence of
high gradient across the aortic valve (60 mm Hg) and
progressive dyspnea on exertion prompted us to perform
a cardiac catheterization. A narrowing of the stent was
found at the middle segment with a measured pull back
gradient of 10 mm Hg across it. We proceeded to re-
dilate the stent successfully (Fig. 2b). The aortic valve
gradient was 30 mm Hg. Currently, the patient is asymp-
tomatic and receiving anti-hypertensive medications in
addition to aspirin and ACE-inhibitor.
Discussion
Due to high morbidity and mortality, the CoA should be
diagnosed and corrected early in life. The common
complications of un-treated CoA in adults include hy-
pertension, premature coronary artery disease, sudden
Fig. 1 a Descending aortogram showing a blind distal aortic segment below the involved segment. b Descending aortogram showing a
guide-wire across the atretic membrane of the aortic lumen
Fig. 2 a Aortogram showing placement of a stent across the coarctation of the aorta. b Follow-up CT angiogram showing a patent stent and the
lumen of the aorta. (AO- Ascending aorta, DO- descending aorta)
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cardiac death, heart failure, stroke, endocarditis, rupture,
dissection, aneurysm and cardiovascular disease [4–8].
However, due to rarity in adults, benefits of early repair
are unclear. Therapeutic goals in adult patients include
symptomatic improvement, control of hypertension and
an intervention which is suitable for individual patient.
So far, there is no consensus on the indications of
surgical and percutaneous interventions in older patients
[10–13]. Historically, the mortality rate in unrepaired
CoA is 90 % by 50–years of age, with a mean age of
35 years [7–9].
In view of the rapid advance in the imaging and inter-
ventional technologies, the number of such case reports
may increase in future. Therefore, it is pertinent to dis-
cuss similar cases for a better understanding and man-
agement. Traditional surgical resection, patch repair and
interposition graft placement techniques are well known
for an uncomplicated juvenile CoA [8–10]. However,
due to high risks involved with invasive procedures in
adult population, a minimal invasive approach such as
percutaneous intervention is a preferred therapeutic
approach in recent times. The tissue characteristics,
chronic nature of the disease, associated co-morbid con-
ditions and collateral circulation makes adult population
a high–risk group for all interventions especially the
surgical ones [6, 10].
The initial percutaneous approach in the treatment of
the coarctation of the aorta was balloon angioplasty but
endovascular stent placement is gaining wider accept-
ance recently. The incidence of early and late aneurysm
after balloon angioplasty has been reported to be 5–11 %
in different series [6, 12, 13]. This has led to the develop-
ment of balloon-expandable stents and presently there are
covered stents available in the market as a further ad-
vancement. These stents provide support to the vessel
wall, prevent aneurysm formation and amenable to re-
dilatation [6].
Fluoroscopy guided catheter perforation of the atretic
membrane in the aortic lumen lumen through a com-
bined antegrade and retrograde ‘kissing’ technique via
axillary or femoral trans-septal approaches have been
described for stenting [3–5]. We could incidentally man-
aged a gentle perforation of the atretic membrane using
the stiff end of the Terumo wire passed through the
distal end of the involved aorta, thereby, avoided a sec-
ond vascular access. The presence of atretic coarctation
makes transcatheter interventions, a high–risk procedure
due to anticipated inadvertent perforation or failure of the
procedure. Therefore, it is prudent to have a surgical
backup available.
In our patient, we have used the covered Cheatham-
Platinum stent due to expected benefit in terms of a
better long-term result by reducing the possibility of
recurrence or re-intervention [6]. The maximum balloon
diameter is usually chosen based on the diameter of
either the distal aortic arch or the transverse arch with a
maximum oversize of approximately two mm greater.
The length of the stent is calculated as per the distance
between the origins of the left subclavian artery to a
point approximately 15 mm beyond the site of coartation
distally.
A review of the recently published literature has
shown the short and intermediate-term benefits of trans-
catheter stenting techniques (Table 1). However, the pos-
sibility of re-coarctation and need for re-intervention
remains higher [6–13]. The actuarial freedom from the
re-intervention at 60-months after intervention using
stents is approximately 95 % [11]. However, overall short-
term complication rate for endovascular interventions are
32.1 % for balloon angioplasty and 8.3 % for stenting [12].
Similarly, the overall long-term complication rates for
balloon interventions were 43.8 % as compared to 12.5 %
in stent patients [12].
The common long-term complications of transcatheter
interventions are aortic wall injury, dissection, aneurysm,
re-coarctation or stent fracture [11–13]. The recurrence
of coarctation is attributed to the severity of the disease,
fibrotic changes, cystic medial necrosis, intimal tear,
thrombosis and graft-infolding in the involved redundant
aortic segment due to oversizing during initial balloon
Table 1 Follow up data of patients with transcatheter intervention for coarctation of the aorta in adults





the procedure (mm Hg)
Mean increase in diameter
of the involved segment
(mm)
Patients with improvement





Tzifa 'et–al' 2006 30 (covered stents) 28 ± 17.5 4 ± 4 17.1 ± 3.1 43 11
Shennib 'et–al' 2010 22 (13 balloon and
stents, 9 endoluminal
grafts)
40 + 18 4 + 7 19 + 4 100 31 + 15.6
Forbes 'et–al' 2011 61 (ballon angioplasty) 0.4–42.5 ≤10 in 55 % patients Coarctation: Descending
aorta diameter ratio≥ 0.6
in 93 % patients
16 % patients on anti
hypertensive medications
18–60
≤15 in 82 % patients
Forbes 'et–al' 2011 217 (stents) 2.2–74.3 ≤10 in 75 % patients Coarctation: Descending
aorta diameter ratio≥ 0.6
in 89 % patients
31 % patients on anti
hypertensive medications
18–60
≤15 85 % patients
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dilatation or stent placement. The covered stents may
minimize such complications due to the fact that not
only it stabilize the aortic wall but can be re-dilated,
as in our patient.
The covered stents are valuable and recent addition in
the management strategies; therefore, more long-term
data is required to establish their role.
Conclusion
Transcatheter stent dilatation is a safe and acceptable
alternative to surgical repair or balloon angioplasty in
complex atretic CoA. Early and intermediate outcomes
associated with transcatheter interventions including
covered stents appear to be promising. However, there is
a need to explore new frontiers in the management of
adult coarctation of aorta in order to refine the existing
techniques or prevent complications by modifying the
factors influencing short or long-term outcomes.
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